You are here: Industry Insights > COVID-19

News List

FDA issues emergency use authorization for convalescent plasma as potential promising COVID-19 treatment worldpharmanews
August 24, 2020
The U.S. Food and Drug Administration issued an emergency use authorization (EUA) for investigational convalescent plasma for the treatment of COVID-19 in hospitalized patients as part of the agency's ongoing efforts to fight COVID-19.
Trials Underway to Study COVID-19 Impact on Dialysis Patients americanpharmaceuticalreview
August 24, 2020
DaVita Clinical Research (DCR), a subsidiary of DaVita Inc., has begun enrollment on two clinical research trials to study how COVID-19 affects people with end stage kidney disease (ESKD) who are currently receiving dialysis.
Preclinical Study Finds Nafamostat Blocks SARS-CoV-2 Infection in Human Lung Cells americanpharmaceuticalreview
August 24, 2020
A preclinical study testing the generic drug nafamostat in human cells shows it can help block SARS-CoV-2 infection.
Sorrento to merge with gene-encoded therapies firm SmartPharm pharmaceutical-technology
August 24, 2020
Sorrento Therapeutics has entered into a merger agreement to acquire gene-encoded therapeutics firm SmartPharm for an aggregate of up to $19.4m shares of Sorrento common stock.
Research links COVID-19 to rise in childhood type 1 diabetes expresspharma
August 24, 2020
This study analysed data from 30 children in London hospitals diagnosed with new-onset type 1 diabetes during the first peak of the pandemic.
US pharma firm, Advanced Penetration Technology tests FDA-approved ointment to treat COVID-19 expresspharma
August 24, 2020
A research concludes that APT T3X effectively neutralises viral infectivity within seconds and its topical intranasal use can decrease the viral load of exposure.
Remdesivir has only marginal benefit for moderate COVID-19 patients expresspharma
August 24, 2020
The 600-patient analysis found that moderately-ill patients treated with Remdesivir for up to five days had significantly higher odds of improvement compared to a 10-days course.
ICMR developing portal for info on COVID-19 vaccine expresspharma
August 24, 2020
ICMR is in the process of developing a vaccine portal which will provide information related to the COVID-19 vaccine development in India and abroad, with the majority of the updates in several regional languages in addition to English.
Over 617,700 COVID-19 test samples collected in Shenzhen chinadaily
August 22, 2020
More than 617,700 nucleic acid test samples have been collected in the city of Shenzhen, South China's Guangdong province, as part of the latest batch of COVID-19 testing since a new case was detected earlier this month, authorities said on Aug 20.
Achiko extends COVID-19 ecosystem platform in Indonesia biospectrumasia
August 22, 2020
Headquartered in Switzerland, Achiko AG (ACHI) has recently announced the deployment of Teman Sehat to a further, extended number of locations, including hotels, recreation parks, and traditional markets.